1. Home
  2. NAMSW vs HTLFP Comparison

NAMSW vs HTLFP Comparison

Compare NAMSW & HTLFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMSW
  • HTLFP
  • Stock Information
  • Founded
  • NAMSW N/A
  • HTLFP N/A
  • Country
  • NAMSW Netherlands
  • HTLFP United States
  • Employees
  • NAMSW 29
  • HTLFP 1888
  • Industry
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • HTLFP Major Banks
  • Sector
  • NAMSW Health Care
  • HTLFP Finance
  • Exchange
  • NAMSW Nasdaq
  • HTLFP Nasdaq
  • Market Cap
  • NAMSW N/A
  • HTLFP N/A
  • IPO Year
  • NAMSW N/A
  • HTLFP N/A
  • Fundamental
  • Price
  • NAMSW $9.00
  • HTLFP $25.30
  • Analyst Decision
  • NAMSW
  • HTLFP
  • Analyst Count
  • NAMSW 0
  • HTLFP 0
  • Target Price
  • NAMSW N/A
  • HTLFP N/A
  • AVG Volume (30 Days)
  • NAMSW N/A
  • HTLFP N/A
  • Earning Date
  • NAMSW N/A
  • HTLFP N/A
  • Dividend Yield
  • NAMSW N/A
  • HTLFP N/A
  • EPS Growth
  • NAMSW N/A
  • HTLFP N/A
  • EPS
  • NAMSW N/A
  • HTLFP N/A
  • Revenue
  • NAMSW N/A
  • HTLFP N/A
  • Revenue This Year
  • NAMSW N/A
  • HTLFP N/A
  • Revenue Next Year
  • NAMSW N/A
  • HTLFP N/A
  • P/E Ratio
  • NAMSW N/A
  • HTLFP N/A
  • Revenue Growth
  • NAMSW N/A
  • HTLFP N/A
  • 52 Week Low
  • NAMSW N/A
  • HTLFP N/A
  • 52 Week High
  • NAMSW N/A
  • HTLFP N/A
  • Technical
  • Relative Strength Index (RSI)
  • NAMSW 47.49
  • HTLFP 54.40
  • Support Level
  • NAMSW $9.40
  • HTLFP $25.07
  • Resistance Level
  • NAMSW $10.14
  • HTLFP $25.35
  • Average True Range (ATR)
  • NAMSW 0.44
  • HTLFP 0.11
  • MACD
  • NAMSW -0.12
  • HTLFP 0.02
  • Stochastic Oscillator
  • NAMSW 24.31
  • HTLFP 87.50

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About HTLFP Heartland Financial USA Inc. Depositary Shares each representing a 1/400th ownership interest in a share of 7.00% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series E

Heartland Financial USA Inc is a multi-bank holding company that offers a wide range of commercial, small business, and consumer banking services to businesses, including public sector and non-profit entities and individuals. It also provides traditional and non-traditional service channels including online banking, mobile and remote banking, and telephone banking. The company's business lines are Commercial Banking, Agricultural Loans, Small Business Banking, Residential Real Estate Mortgage Lending, Consumer Banking, and Wealth Management and Retirement Plan Services.

Share on Social Networks: